In 2016 The global in vitro diagnostics market is valued at USD 60.22 Billion. Personalized medicine, increasing prevalence of lifestyle and chronic diseases, growth in the number of private diagnostic centers are primary factors driving market growth. Lack of reimbursement and increasing healthcare cost, market growth is restrained. This article study included the usage of both primary and secondary data sources as well as various factors that affects the industry, competitive scenario, including the regulatory landscape; historic data in the market. The in vitro diagnostics market is divided by products & services, application, end user, technology and region. The market is divided into infectious diseases, diabetes, nephrology, oncology/cancer, cardiology, autoimmune diseases, drug testing/pharmacogenomics, HIV/AIDS and others. In 2015, infectious diseases section occupied for the largest share of the market.
Due to the growth in research activities and increasing investments by key players and respective government agencies in the region, The Asia-Pacific region is supposed to register the highest CAGR. The leading players in this market are Dickinson and Company (U.S.), Abbott Laboratories (U.S.), Siemens Healthineers (Germany), Thermo Fisher Scientific, Inc. (U.S.), Sysmex Corporation (Japan), Roche Diagnostics (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux (France), and Becton, Johnson and Johnson (U.S.), Danaher Corporation (U.S.), Qiagen N.V. (Germany), Ortho-Clinical Diagnostics, Inc. (U.S.), and Diasorin S.P.A. (Italy).
The global Market for In Vitro Diagnostic Tests keeping readers informed about progress in all areas of the ivd industry, around the world, in one volume.
Below are the factors that affects on growth of IVD sales:
- Aging Population
- Disease Incidence and Infectious Disease
- New Biomarkers
- Increased Insurance
Estimates growth in the IVD market from range 3% to 4%, but this can be vary depending on section covered. By country and region, IVD procedures will vary for Demand patterns and growth prospects.
Below are the companies involved in IVD market:
- Abbott Laboratories
- Siemens AG
- Qiagen N.V.
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- Ortho Clinical Diagnostics
- Becton, Dickinson And Company
The selection procedure of IVD by medical suppliers depends on a various of factors. Important driving factors for IVD market:
- Increasing adaptation of point of care testing.
- Demand for technologically advanced testing methods for disease diagnosis
- Increasing incidences of chronic lifestyle diseases
in 2016, immunochemistry techniques accounted for the highest sharein-vitro diagnos